Exhibit 16.1

July 15, 2026

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by Regen BioPharma Inc (the “Company”) under Item 4.01 of its Form 8-K dated July 15, 2026. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of the Company contained therein.